Lung cancer combo trial halted early: what we know
Disease control
Terminated
This study tested a combination of three drugs (SHR-1210, famitinib, and chemotherapy) in people with advanced non-squamous non-small-cell lung cancer who had not received prior chemotherapy. The goal was to see if the combo could slow cancer growth better than a placebo plus che…
Phase: PHASE3 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Apr 26, 2026 19:39 UTC